Trinity Biotech plans 1-for-30 reverse ADS split By Investing.com
Trinity Biotech plc announced a 1-for-30 reverse ADS split, changing its American depositary share ratio to one ADS representing 600 Class A ordinary shares. This move aims to help the company regain compliance with Nasdaq's $1.00 minimum bid price requirement and attract investors who …